by
Barbara Kram, Editor | October 15, 2007
Kevin Hutchinson, president and CEO of SureScripts, discussed e-prescribing, particularly the benefits of having all 50 states and DC clearing regulations to permit e-prescribing.
During closing remarks, Sen. Whitehouse offered the following observations:

Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
1. Pay attention to Sen. Kennedy's guidance and request on jurisdictional matters
2. Collaboration on the priority for problems and fixes in HIT. The Senate is hearing from too many competing voices.
3. Industry needs to help Congress define the infrastructure issues (what is the equivalent to street paving in the HIT world) that Congress should be funding, and what are the investment issues that providers as small businesses should be funding.
Senator Stabenow reiterated short- and long-term tasks have been helpful to the Senators. In particular, they will be focusing on DEA e-prescribing of controlled substances restrictions and whether e-prescribing should be independent or in conjunction with EHR adoption initiatives.
Participating Senators included:
Senator Harry Reid, Nevada,
Majority Leader
Senator Dick Durbin, Illinois,
Assistant Majority Leader
Senator Debbie Stabenow, Michigan, Steering and Outreach Comm. Chairperson
Senator Ted Kennedy, Massachusetts,
Chairman of the HELP Committee
Senator Ken Salazar, Colorado
Senator John Tester, Montana
Senator Jeff Bingaman, New Mexico
Senator Sheldon Whitehouse, Rhode Island
Senator Ben Cardin, Maryland
Senator Ron Wyden, Oregon
Senator Blanche Lambert Lincoln, Arkansas
Senator Amy Klobuchar, Minnesota
Participating Staff included:
Tom Russell, Staff Director of the DSOC
David Bowen, Senate HELP Committee
David Schwartz, Senate Finance Committee
Jordana Levinson, Health Policy Advisor to Senator Whitehouse
Back to HCB News